πŸ‡ΊπŸ‡Έ FDA
Patent

US 12030896

PIKfyve inhibitors

granted A61KA61K31/437A61K31/53

Quick answer

US patent 12030896 (PIKfyve inhibitors) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/437, A61K31/53, A61K31/5377, A61K31/538